Startseite Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Assessing the harmonization of current total vitamin B12 measurement methods: relevance and implications

  • Bruno Mario Cesana ORCID logo , Simona da Molin , Nuthar Jassam ORCID logo , Julian H. Barth , Sabrina Buoro ORCID logo , Martina Tosi , Gianvincenzo Zuccotti , Santica Marcovina ORCID logo und Simona Ferraro ORCID logo EMAIL logo
Veröffentlicht/Copyright: 20. August 2025
Veröffentlichen auch Sie bei De Gruyter Brill

Abstract

Objectives

The UK National Institute for Health and Care Excellence has recommended thresholds for total vitamin B12 (B12) assays with interchangeable results for identifying B12 deficiency. We assessed the agreement between B12 methods, to evaluate whether the thresholds may be assumed applicable to all assays.

Methods

A total of 19 External Quality Assessment (EQA) exercises (1791 determinations) based on human subjects-pool materials and 97 serum samples were retrieved to characterize the agreement between Alinity and Architect (Abbott Diagnostics), Access DXi (Beckman Coulter Diagnostics), Atellica and ADVIA Centaur (Siemens Healthcare Solution) compared to Cobas (Roche Diagnostics), considered as comparator because its calibrator traceability to the World Health Organisation (WHO) International Standard (IS) code 03/178. Ordinary least squares and Bland-Altman were used for this purpose.

Results

Abbott and Beckman methods overestimated and underestimated, respectively, B12 concentrations vs. Roche and the other methods. We reported similar systematic or proportional error patterns between EQA and serum samples. Only Beckman was affected by both errors. Due to the wide Limit of Agreement Interval, we cannot confidently conclude on the agreement between Roche and the other methods. However, the inter-method bias was well lower than the desirable goal of 9.4 % for Abbott Architect and also lower for Siemens ADVIA Centaur.

Conclusions

The recommended thresholds for serum total B12 should not be assumed applicable to all assays, due to the poor agreement among the currently available methods, a limitation that persists despite the release of the WHO IS 03/178.


Corresponding author: Simona Ferraro, Center of Functional Genomics and Rare diseases, Department of Pediatrics, Buzzi Children’s Hospital, Milan, Italy, E-mail:

Acknowledgments

The authors thank Fabio Pasotti, Duilio Brugnoni working on B12 EQA program of the Italian Regional Coordination Center for Laboratory Medicine (Lombardy).

  1. Research ethics: The study was approved by the National Research Ethics Committee (Ref 11/H/1302/5).

  2. Informed consent: Not applicable.

  3. Author contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data; (b) drafting or revising the article for intellectual content; (c) final approval of the published article; and (d) agreement to be accountable for all aspects of the article thus ensuring that questions related to the accuracy or integrity of any part of the article are appropriately investigated and resolved. S. Ferraro, conceptualization (lead) and writing original draft (equal); B.M. Cesana formal analysis (lead) and writing original draft (equal); S. daMolin, resources (equal); S. Buoro, resources (lead); N Jassam resources (equal); JH Barth resources (equal); S. Marcovina: reviewing and editing (lead); M.Tosi reviewing and editing (supporting); GV Zuccotti reviewing and editing (supporting).

  4. Use of Large Language Models, AI and Machine Learning Tools: Not applicable.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: The raw data can be obtained on request from the corresponding author.

References

1. Ferraro, S, Lucchi, S, Montanari, C, Magnani, L, Tosi, M, Biganzoli, D, et al.. Vitamin B12 deficiency in newborns: impact on individual’s health status and healthcare costs. Clin Chem Lab Med 2024;63:559–71. https://doi.org/10.1515/cclm-2024-0692.Suche in Google Scholar PubMed

2. Moore, E, Mander, A, Ames, D, Carne, R, Sanders, K, Watters, D. Cognitive impairment and vitamin B12: a review. Int Psychogeriatr 2012;24:541–56. https://doi.org/10.1017/s1041610211002511.Suche in Google Scholar

3. Ferraro, S, Da Molin, S, Cereda, C, Zuccotti, G, Marcovina, S, Cesana, BM. Vitamin B12 deficiency and new recommendations by the National Institute for Health and Care Excellence: a challenging clinical and laboratory topic. Clin Chem 2025. https://doi.org/10.1093/clinchem/hvaf037 [Online ahead of print].Suche in Google Scholar PubMed

4. Vitamin B12 deficiency in over 16s: diagnosis and management [C] Evidence review for diagnostic tests NICE guideline NG239. Evidence reviews underpinning recommendations 1.3.1 to 1.3.16 and recommendations for research in the NICE guideline March 2024: https://pubmed.ncbi.nlm.nih.gov/38713783/# [Accessed Dec 2024].Suche in Google Scholar

5. Ferraro, S, Cereda, C, Zuccotti, G. Biochemical evidence of vitamin B12 deficiency: a crucial issue to address supplementation in pregnant women. Clin Chem Lab Med 2025. https://doi.org/10.1515/cclm-2024-1405 [Ahead of print].Suche in Google Scholar PubMed

6. Ferraro, S, Panteghini, M. Folate and vitamin B12 assays after recalibration to the WHO International Standard 03/178: making the interpretation as simple as possible, but not simpler. Clin Chem Lab Med 2019;57:1112–4. https://doi.org/10.1515/cclm-2019-0050.Suche in Google Scholar PubMed

7. İspir, E, Serdar, MA, Ozgurtas, T, Gulbahar, O, Akın, KO, Yesildal, F, et al.. Comparison of four automated serum vitamin B12 assays. Clin Chem Lab Med 2015;53:1205–13. https://doi.org/10.1515/cclm-2014-0843.Suche in Google Scholar PubMed

8. Braga, F, Frusciante, E, Ferraro, S, Panteghini, M. Trueness evaluation and verification of inter-assay agreement of serum folate measuring systems. Clin Chem Lab Med 2020;58:1697–705. https://doi.org/10.1515/cclm-2019-0928.Suche in Google Scholar PubMed

9. van der Hagen, E, Weykamp, C, Sandberg, S, Stavelin, A, MacKenzie, F, Miller, W. Feasibility for aggregation of commutable external quality assessment results to evaluate metrological traceability and agreement among results. Clin Chem Lab Med 2021;59:117–25. https://doi.org/10.1515/cclm-2020-0736.Suche in Google Scholar PubMed

10. van Rossum, HH, Holdenrieder, S, Ballieux, BEPB, Badrick, TC, Yun, YM, Zhang, C, et al.. Investigating the current harmonization status of tumor markers using global external quality assessment programs: a feasibility study. Clin Chem 2024;70:669–79. https://doi.org/10.1093/clinchem/hvae005.Suche in Google Scholar PubMed

11. Jassam, N, Bancroft, T, Luvai, A, Mbagaya, W, Barth, JH. Vitamin B12 reference intervals on Beckman, Roche and Siemens analytical platforms. Ann Clin Biochem 2023;60:417–22. https://doi.org/10.1177/00045632231202211.Suche in Google Scholar PubMed

12. Ozarda, Y, Ichihara, K, Barth, JH, Committee on Reference Intervals and Decision Limits (C-RIDL), International Federation for Clinical Chemistry and Laboratory Medicine. Protocol and standard operating procedures for common use in a worldwide multicenter study on reference values. Clin Chem Lab Med 2013;51:1027–40. https://doi.org/10.1515/cclm-2013-0249.Suche in Google Scholar PubMed

13. Clinical and Laboratory Standards Institute (CLSI). EP09-A3 – measurement procedure comparison and bias estimation using patient samples; approved guideline, 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2013.Suche in Google Scholar

14. Goedhart, J, Rishniw, M. BA-plotteR – a web tool for generating Bland-Altman plots and constructing limits of agreement. Res Vet Sci 2021;137:281–6. https://doi.org/10.1016/j.rvsc.2021.05.017.Suche in Google Scholar PubMed

15. Cesana, BM, Antonelli, P. Bland-Altman agreement method: to plot differences against means or differences against standard? An endless tale? Clin Chem Lab Med 2024;62:262–9. https://doi.org/10.1515/cclm-2023-0306.Suche in Google Scholar PubMed

16. https://biologicalvariation.eu/search?query=Cobalamin Suche in Google Scholar

17. Sandberg, S, Coskun, A, Carobene, A, Fernandez-Calle, P, Diaz-Garzon, J, Bartlett, WA, et al.. Analytical performance specifications based on biological variation data - considerations, strengths and limitations. Clin Chem Lab Med 2024;62:1483–9. https://doi.org/10.1515/cclm-2024-0108.Suche in Google Scholar PubMed

18. Ferraro, S, Mozzi, R, Panteghini, M. Tracing a roadmap for vitamin B12 testing using the health technology assessment approach. Clin Chem Lab Med 2014;52:767–77. https://doi.org/10.1515/cclm-2013-0738.Suche in Google Scholar PubMed

19. Carmel, R, Brar, S, Agrawal, A, Penha, PD. Failure of assay to identify low cobalamin concentrations. Clin Chem 2000;46:2017–8. https://doi.org/10.1093/clinchem/46.12.2017.Suche in Google Scholar

20. Bowen, R, Benavides, R, Colón-Franco, JM, Katzman, BM, Muthukumar, A, Sadrzadeh, H, et al.. Best practices in mitigating the risk of biotin interference with laboratory testing. Clin Biochem 2019;74:1–11. https://doi.org/10.1016/j.clinbiochem.2019.08.012.Suche in Google Scholar PubMed

21. Pant, V, Tumbapo, A, Yadav, BK. Vitamin B12 immunoassay interference in a patient with multiple myeloma – troubleshooting in a two-step reagent kit based on enhanced chemiluminescence testing. EJIFCC 2018;29:152–5.Suche in Google Scholar

22. Basu, S, Chaudhuri, S. Vitamin B(12) immunoassay on Roche elecsys 2010: effects of high excess concentration of serum vitamin B(12) in CKD patients on parenteral administration. Indian J Clin Biochem 2011;26:413–5. https://doi.org/10.1007/s12291-011-0129-z.Suche in Google Scholar PubMed PubMed Central

23. Wolffenbuttel, BHR, Muller Kobold, AC, Sobczyńska-Malefora, A, Harrington, DJ. Macro-B12 masking B12 deficiency. BMJ Case Rep 2022;15:e247660. https://doi.org/10.1136/bcr-2021-247660.Suche in Google Scholar PubMed PubMed Central

24. Oberley, MJ, Yang, DT. Laboratory testing for cobalamin deficiency in megaloblastic anemia. Am J Hematol 2013;88:522–6. https://doi.org/10.1002/ajh.23421.Suche in Google Scholar PubMed

25. Carmel, R. Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II. Am J Clin Nutr 2011;94:348S–358S. https://doi.org/10.3945/ajcn.111.013441.Suche in Google Scholar PubMed PubMed Central

26. Green, R. Unreliability of current assays to detect cobalamin deficiency: “nothing gold can stay”. Blood 2005;105:910–1. https://doi.org/10.1182/blood-2004-11-4293.Suche in Google Scholar


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0939).


Received: 2025-04-02
Accepted: 2025-08-12
Published Online: 2025-08-20

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 16.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0939/html
Button zum nach oben scrollen